Skip to main content
OrbusNeich Medical Group Holdings Ltd. logo

OrbusNeich Medical Group Holdings Ltd. — Investor Relations & Filings

Ticker · 6929 HKEX Manufacturing
Open in API
Filings indexed 138 across all filing types
Latest filing 2025-05-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6929

About OrbusNeich Medical Group Holdings Ltd.

https://orbusneich.com

OrbusNeich Medical Group Holdings Ltd. is a medical device company engaged in the design, development, manufacturing, and distribution of interventional medical devices for the treatment of vascular diseases. The company's primary focus is on endovascular instruments utilized in procedures such as Percutaneous Coronary Intervention (PCI) and Percutaneous Transluminal Angioplasty (PTA). Key product offerings include innovative coronary stents, specialty catheters, and PTA/PCI balloons. OrbusNeich is strategically expanding its technological platform to address structural heart disease and neuro vascular intervention markets, maintaining a commitment to delivering advanced solutions that enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly regulatory return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised share capital, issued shares, treasury shares, share options, etc. It is not an announcement of a one‐off transaction (e.g., share issue or repurchase), nor an earnings release or AGM material. It is a periodic regulatory submission that does not match any more specific category, so it falls under Regulatory Filings (RNS).
2025-05-02 English
Notification Letter to Registered Shareholders - Notice of Publication of 2024 Annual Report, Circular including Notice of Annual General Meeting and Proxy Form and Environmental, Social and Governanc
Report Publication Announcement Classification · 1% confidence The document is a notification letter addressed to shareholders informing them that the 2024 Annual Report, the AGM circular (including proxy form), and the 2024 ESG Report have been published electronically and providing instructions for accessing or requesting printed copies. There is no actual financial data or detailed reporting within the text; instead it announces the availability of those reports on the HKEX and company websites. This matches the definition of a Report Publication Announcement (RPA): an announcement regarding the release or publication of company reports.
2025-04-16 English
Form of Proxy for use at the Annual General Meeting to be held on May 27, 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Form of Proxy” for the Annual General Meeting, which is a proxy solicitation document sent to shareholders asking them to appoint proxies and vote on resolutions. This falls squarely under the “Proxy Solicitation & Information Statement” category (PSI). It is not the AGM presentation itself, nor a regulatory announcement or report publication notice.
2025-04-16 English
Notice of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice convening the Annual General Meeting, listing agenda items, resolutions, proxy appointment procedures, record dates, and voting details. It is sent to shareholders to provide information on the upcoming meeting and solicit their votes. This falls under Proxy Solicitation & Information Statement (materials sent to shareholders to request votes for meetings).
2025-04-16 English
(1) Proposed Re-election of Retiring Directors, (2) Proposed Grant of General Mandates to Issue Shares and to Repurchase Shares, (3) Re-appointment of Auditor, (4) Declaration and Payment of the Final
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular from a Hong Kong–listed company, containing agenda items for the upcoming Annual General Meeting, explanatory statements, details on resolutions (re-election of directors, share mandates, auditor re-appointment, dividend declaration), and a proxy form with voting instructions. It is clearly a solicitation of proxies and information statement sent to shareholders ahead of the AGM. This aligns with the Proxy Solicitation & Information Statement category (Code: PSI).
2025-04-16 English
Environmental, Social and Governance Report 2024
Environmental & Social Information Classification · 1% confidence The document is a standalone report titled “Environmental, Social and Governance Report 2024” for OrbusNeich Medical Group Holdings Limited. It covers comprehensive ESG performance, methodology, governance structure, stakeholder engagement, certifications, and KPIs for the year ended December 31, 2024. This aligns directly with the definition of an Environmental & Social Information report (ESG/disclosure). It is neither a brief summary nor an announcement of another report, but the full ESG report itself.
2025-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.